Exploring the Effects of Omalizumab in Allergic Asthma

Narrative Review: The Role of Th2 Immune Pathway Modulation in the Treatment of Severe Asthma and Its Phenotypes

(2013) Stewart J. Levine   ANNALS OF INTERNAL MEDICINE

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

(2013) Nicola A. Hanania et al.   ANNALS OF INTERNAL MEDICINE

Asthma outcomes: Biomarkers

(2012) Stanley J. Szefler et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

(2012) Guiquan Jia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

(2011) J. Bousquet et al.   ALLERGY

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications

(2011) Raed A. Dweik et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Development of the Asthma Control Composite outcome measure to predict omalizumab response

(2011) Jeffrey M. Harris et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Lebrikizumab Treatment in Adults with Asthma

(2011) Jonathan Corren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

(2011) William W. Busse et al.   NEW ENGLAND JOURNAL OF MEDICINE

Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma

(2010) M. Kulus et al.   CURRENT MEDICAL RESEARCH AND OPINION

Lessons learned from variation in response to therapy in clinical trials

(2010) Stanley J. Szefler et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment Effect Pattern Plot

(2010) Ann A. Lazar et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship between pretreatment specific IgE and the response to omalizumab therapy

(2009) U. Wahn et al.   ALLERGY

T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma

(2009) Prescott G. Woodruff et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

(2009) Helen K. Reddel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Safety and tolerability of omalizumab

(2009) J. Corren et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma

(2009) Bob Lanier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Effect of omalizumab on peripheral blood eosinophilia in allergic asthma

(2009) M. Massanari et al.   RESPIRATORY MEDICINE

IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells

(2008) K. Chibana et al.   CLINICAL AND EXPERIMENTAL ALLERGY

The cytokine network in asthma and chronic obstructive pulmonary disease

(2008) Peter J. Barnes   JOURNAL OF CLINICAL INVESTIGATION